PortfoliosLab logo

Myriad Genetics, Inc. (MYGN)

Equity · Currency in USD
Sector
Healthcare
Industry
Diagnostics & Research
ISIN
US62855J1043
CUSIP
62855J104

MYGNPrice Chart


Chart placeholderClick Calculate to get results

MYGNPerformance

The chart shows the growth of $10,000 invested in Myriad Genetics, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $9,895 for a total return of roughly -1.05%. All prices are adjusted for splits and dividends.


MYGN (Myriad Genetics, Inc.)
Benchmark (S&P 500)

MYGNReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD-4.42%-3.97%
1M6.07%-0.94%
6M-11.98%7.48%
1Y-1.24%21.47%
5Y10.82%15.05%
10Y1.73%13.31%

MYGNMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

MYGNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Myriad Genetics, Inc. Sharpe ratio is -0.06. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


MYGN (Myriad Genetics, Inc.)
Benchmark (S&P 500)

MYGNDividends


Myriad Genetics, Inc. doesn't pay dividends

MYGNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


MYGN (Myriad Genetics, Inc.)
Benchmark (S&P 500)

MYGNWorst Drawdowns

The table below shows the maximum drawdowns of the Myriad Genetics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Myriad Genetics, Inc. is 80.57%, recorded on Mar 18, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-80.57%Sep 5, 2018386Mar 18, 2020
-66.64%Nov 5, 2015316Feb 7, 2017388Aug 22, 2018704
-46.17%Jan 7, 2010136Jul 22, 2010539Sep 10, 2012675
-39.32%Jun 12, 2013140Dec 30, 201333Feb 18, 2014173
-26.7%May 1, 2014321Aug 7, 201557Oct 28, 2015378
-21.08%Nov 27, 201255Feb 14, 201359May 10, 2013114
-14.2%Mar 10, 201413Mar 26, 20145Apr 2, 201418
-10.65%May 15, 201315Jun 5, 20134Jun 11, 201319
-10.42%Oct 5, 201213Oct 23, 20128Nov 6, 201221
-7.37%Apr 7, 20149Apr 17, 20148Apr 30, 201417

MYGNVolatility Chart

Current Myriad Genetics, Inc. volatility is 59.35%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


MYGN (Myriad Genetics, Inc.)
Benchmark (S&P 500)

Portfolios with Myriad Genetics, Inc.


Loading data...

More Tools for Myriad Genetics, Inc.